Τρίτη 5 Μαΐου 2020

How to Compare the Efficacy of Biologic Agents in Asthma
Asthma affects approximately 10% of the U.S. population and worldwide it is estimated that 300 million people are affected by this disease (www.ginaasthma.org; www.cdc.gov/asthma). One of the emerging and important aspects of asthma is its heterogeneity, which is reflected in many of its characteristics: onset of disease, severity, persistence, and responsiveness to treatment.1 The subpopulations with severe asthma are of particular importance as they are characterized by incomplete or absent responses...
Annals of Allergy, Asthma & Immunology
Tue May 05, 2020 03:00
Managing FPIES during the COVID-19 pandemic-expert recommendations
Food protein-induced enterocolitis syndrome (FPIES) is a non IgE-mediated food allergy that manifests with predominantly gastrointestinal symptoms characterized by repetitive emesis, starting 1-4 hours (typically 2 hours) after food ingestion with or without watery diarrhea that may follow within 6-10 hours. (1) FPIES usually starts in the first year of life; the most commonly reported triggers in infants include cow's milk, soy, rice, and oat, followed by fruits, vegetables, egg, and fish (Mediterranean...
Annals of Allergy, Asthma & Immunology
Tue May 05, 2020 03:00
Superior Turbinate Eosinophilia Predicts Olfactory Decline in Patients with Chronic Rhinosinusitis
Predicting the postoperative olfactory decline in patients with chronic rhinosinusitis (CRS) remains a significant challenge.
Annals of Allergy, Asthma & Immunology
Tue May 05, 2020 03:00
The Clinical Observation of a CVID Patient Infected with COVID-19
In December 2019 a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was first reported in the Wuhan region of China.1 SARS-CoV-2, also known as coronavirus disease 2019 (COVID-19) is a beta coronavirus with structural similarities to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).1,2 Due to the rapid spread of SARS-CoV-2 the World Health Organization declared a pandemic on March 11, 2020.1,2 The spectrum of disease severity ranges from asymptomatic to life...
Annals of Allergy, Asthma & Immunology
Tue May 05, 2020 03:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου